Evidence map›Paper›PMID 41532276›Full record

ArticleClinical transplantation2026

Prolonged Invasive Mechanical Ventilation is Associated With Decreased Survival After Lung Transplantation Among Recipients With Primary Graft Dysfunction: A Lung Transplant Outcomes Group Study.

Meghan Aversa, Shaf Keshavjee, Tereza Martinu, Marcelo Cypel, Andrew T Sage, Joshua M Diamond, Jonathan P Singer, Scott M Palmer, Krishna Pandya, Edward Cantu and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Meghan AversaUniversity of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-7361-0024
Shaf KeshavjeeUniversity of Toronto, Toronto, Ontario, Canada.
Tereza MartinuUniversity of Toronto, Toronto, Ontario, Canada.
Marcelo CypelUniversity of Toronto, Toronto, Ontario, Canada.
Andrew T SageUniversity of Toronto, Toronto, Ontario, Canada.
Joshua M DiamondUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-3695-4637
Jonathan P SingerUniversity of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-0224-7472
Scott M PalmerDuke University, Durham, North Carolina, USA.
Krishna PandyaUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.
Edward CantuUniversity of Kentucky, Lexington, Kentucky, USA.
Jason D ChristieUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.
Michaela R AndersonUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-9274-7643

Funding

Cardiology & pulmonary research training grantT32HL007891 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Jason D Christie · 1998 to 2026
$12.0M
Long Term Follow up of the Lung Transplant Outcomes Group CohortU01HL145435 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D, PALMER, SCOTT M · 2019 to 2025
$10.2M
Clinical Risk Factors for Primary Graft DysfunctionR01HL087115 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2007 to 2017
$7.1M
Objective Lung Assessment Tools for Improved Organ Use in Lung TransplantationR01HL155821 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CANTU, EDWARD · 2021 to 2025
$3.0M
Mentored Patient Oriented Research in Lung TransplantationK24HL115354 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2012 to 2021
$1.2M
Role of visceral adipose tissue in frailty among patients with Idiopathic Pulmonary FibrosisK23HL150280 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ANDERSON, MICHAELA RESTIVO · 2020 to 2024
$854k
Molecular phenotypes of frailty in lung transplantationK24HL174231 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jonathan Paul Singer · 2024 to 2026
$378k
by National Institute of HealthNHLBI NIH HHS K23 HL150280NHLBI NIH HHS K24 HL115354NHLBI NIH HHS K24 HL174231NHLBI NIH HHS K24HL174231NHLBI NIH HHS R01 HL087115NHLBI NIH HHS R01 HL155821NHLBI NIH HHS T32 HL007891NHLBI NIH HHS U01 HL145435
6 · The paper itself

Abstract

introductionProlonged invasive mechanical ventilation (IMV) after lung transplantation is an appealing early prognostic outcome as it can be reproducibly assessed both prospectively and retrospectively. Whether use of IMV at 72 h after lung transplantation is associated with post-transplant graft survival is unknown.

methodsWe performed a retrospective cohort study of 1511 participants in the multi-center Lung Transplant Outcomes Group cohort (2011-2018). Using Cox proportional hazards models and restricted mean survival time, we investigated whether IMV at 72 h was associated with post-transplant graft survival. We secondarily evaluated whether IMV at 72 h was concordant with severe primary graft dysfunction (PGD).

resultsParticipants requiring IMV at 72 h after transplant were sicker at transplantation (higher lung allocation score [LAS], increased extracorporeal membrane oxygenation, or IMV bridge) and more likely to have severe PGD. Use of IMV at 72 h was associated with 55% (95% CI 26%-92%) increased hazards of death or re-transplantation after adjustment for age, ECMO, diagnosis, LAS, and intra-operative transfusion. The association between IMV and graft survival was modified by severe PGD (p-for interaction 0.002) but not by pre-transplant ECMO (p-for interaction 0.88) or pre-transplant IMV (p-for interaction 0.92). IMV was associated with increased risk of death or re-transplantation among those with PGD (HR 2.35, 95% CI 1.43-3.85) but not among those without PGD (HR 1.04, 95% CI 0.77-1.41).

conclusionRequirement of IMV at 72 h is an important early post-transplant outcome associated with post-transplant survival. This appears driven by those with severe PGD.

Indexed as

Graft RejectionLung TransplantationPostoperative ComplicationsPrimary Graft DysfunctionRespiration, ArtificialAdultFemaleFollow-Up StudiesGraft SurvivalHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsSurvival Rateinvasive mechanical ventilationlung transplantationprimary graft dysfunction

Identifiers

PMID41532276
PMCPMC12801094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.